| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Australia | 3 | |
| #3 | United States | 2 | |
| #4 | Canada | 1 | |
| #5 | Hungary | 1 | |
| #6 | Slovakia | 1 | |
| #7 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Climate change adaptation technologies | |
| #4 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Egerland Ute | 10 |
| #2 | Hofgen Norbert | 6 |
| #3 | Kuss Hildegard | 6 |
| #4 | Hoefgen Norbert | 6 |
| #5 | Schindler Rudolf | 5 |
| #6 | Malamas Michael S | 4 |
| #7 | Erdei James Joseph | 4 |
| #8 | Stange Hans | 4 |
| #9 | Ni Yike | 4 |
| #10 | Langen Barbara | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2012080329A1 | Formulations of n-(3,5-dichloropyridin-4-yl)-[1-(4-fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide | |
| WO2012072727A1 | Crystalline modification of n-(3,5-dichloropyridin-4-yl)-[1-(4 -fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide as inhibitor of pde4 | |
| WO2010054260A1 | Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases | |
| AU2008329775A1 | Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |